What are the next steps for a patient with an end-tidal CO2 (etCO2) of 36 and oxygen saturation (SpO2) of 97%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

End-Tidal CO2 of 36 mmHg with SpO2 97%: Clinical Management

These values are within normal physiologic ranges and require continued monitoring without immediate intervention. An etCO2 of 36 mmHg is normal (normal range 35-45 mmHg), and SpO2 of 97% exceeds the standard target saturation of 94-98% for patients without risk of hypercapnic respiratory failure 1.

Immediate Assessment

  • Verify the clinical context: Determine if this patient is intubated, on non-invasive ventilation, or spontaneously breathing, as etCO2 reliability varies significantly across these scenarios 2
  • Assess for risk factors for hypercapnic respiratory failure: If the patient has COPD, morbid obesity, chest wall deformities, neuromuscular disorders, or cystic fibrosis, adjust target SpO2 to 88-92% and obtain arterial blood gas 1
  • Monitor respiratory rate and work of breathing: Tachypnea (>30 breaths/min) indicates respiratory distress requiring immediate intervention even with adequate SpO2 3

Oxygen Management Based on Current Values

  • Do not initiate or increase supplemental oxygen with SpO2 at 97%, as this exceeds the target range and unnecessary oxygen can be harmful 1, 3
  • If patient is currently on supplemental oxygen, consider weaning if clinically stable and SpO2 has been in the upper zone of target range (94-98%) for 4-8 hours 1
  • Target SpO2 of 94-98% for most patients, or 88-92% if at risk of hypercapnic respiratory failure 1

Monitoring Strategy

  • Continue monitoring SpO2 at regular intervals (at least every 4 hours for stable patients, continuously for critically ill patients) 1
  • Recognize etCO2 limitations in non-intubated patients: In spontaneously breathing patients, etCO2 often shows poor sensitivity to changes in minute ventilation and may not reliably reflect PaCO2 2, 4
  • Consider arterial blood gas if clinical concern exists despite normal pulse oximetry, as SpO2 may not reflect ventilation adequacy or developing hypercapnia 3, 5

Key Clinical Pitfalls

  • Do not rely solely on etCO2 in non-intubated patients: Research demonstrates that etCO2 has inadequate sensitivity for detecting ventilation changes in spontaneously breathing patients, with approximately 50% showing poor correlation between etCO2 and minute ventilation 2
  • Avoid over-oxygenation: Even modest elevations above target ranges can be harmful, particularly in patients at risk of hypercapnic respiratory failure 1, 3
  • In severely injured or critically ill patients, etCO2 significantly underestimates PaCO2: The discrepancy increases with severity of illness, acidosis, and mortality risk 4

When to Escalate Care

  • Obtain arterial blood gas if: Patient develops unexplained confusion, agitation, clinical deterioration, or if at risk of hypercapnic respiratory failure with target SpO2 88-92% 1, 3
  • Measure blood gases within 30-60 minutes for patients with target saturation 88-92% to ensure CO2 is not rising 1
  • Clinical review required if: SpO2 falls below target range, respiratory rate >30 breaths/min, or signs of respiratory distress develop 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Patient with SpO2 96% on Room Air Without Known CO2 Retention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Utility of Prehospital Quantitative End Tidal CO2?

Prehospital and disaster medicine, 2013

Guideline

Breathlessness on Low-Dose Clozapine with Normal Oxygen Saturation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.